---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-044912"
form_type: "8-K"
ticker: "STIM"
cik: "0001227636"
company_name: "Neuronetics, Inc."
filed_at: "2026-02-10T23:59:59+00:00"
generated_at: "2026-05-16T03:31:35.858579+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Neuronetics reports preliminary Q4 2025 revenue $41.8M, up 23% pro forma; positive operating cash flow

## Summary
- Q4 revenue $41.8M, 23% YoY pro forma growth; NeuroStar revenue $18.3M (+9% pro forma).
- Full year 2025 revenue $149.2M, 15% pro forma growth; clinic revenue $87.0M (+28% pro forma).
- Q4 operating cash flow positive $0.9M; total cash $34.1M at year-end.
- 49 NeuroStar systems shipped in Q4.
- Final Q4 results to be released March 17, 2026.

## SEC filing metadata
- accession: 0001193125-26-044912
- form_type: 8-K
- ticker: STIM
- cik: 0001227636
- company_name: Neuronetics, Inc.
- filed_at: 2026-02-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1227636/000119312526044912/0001193125-26-044912-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1227636/000119312526044912/d109652d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-044912
- JSON: https://secwatch.observer/filing/0001193125-26-044912.json
- Plain text: https://secwatch.observer/filing/0001193125-26-044912.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.